PCR検査の世界市場

PCR検査の世界市場は2030年までに325億米ドルに達する見込み

2024年に238億米ドルと推定されるPCR検査の世界市場は、2024年から2030年にかけてCAGR 5.4%で成長し、2030年には325億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである標準PCR検査は、CAGR 7.1％を記録し、分析期間終了までに148億米ドルに達すると予測されます。リアルタイムPCR検査セグメントの成長率は、分析期間でCAGR 3.6％と推定されます。

米国市場は65億米ドルと推定、中国はCAGR8.8%で成長予測

米国のPCR検査市場は2024年に65億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.8%で推移し、2030年には市場規模が66億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.4％と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界のPCR検査市場- 主要動向と促進要因のまとめ

PCR検査が分子診断のゴールドスタンダードであり続ける理由とは？

ポリメラーゼ連鎖反応（PCR）検査は、その高い特異性、感度、および病原体、遺伝的状態、腫瘍学バイオマーカーなど幅広いスペクトルの核酸を検出する汎用性により、分子診断学の最前線に立ち続けています。当初は基礎研究のためのツールとして導入されたが、PCRは臨床診断、食品安全検査、法医学的分析、環境モニタリングの中心的存在となりました。その応用はCOVID-19パンデミックの際に世界的に急増し、その関連性は日常診断と精密医療にわたって進化し続けています。

感染症診断では、PCRは依然として活動性感染を確認するためのゴールドスタンダードであり、リアルタイム定量PCR（qPCR）とマルチプレックスPCRシステムは、迅速なターンアラウンドと複数の標的を同時に検出する能力を提供します。これらの能力は呼吸器感染症（例、インフルエンザ、RSV、SARS-CoV-2）、性感染症、デング熱やジカ熱などの熱帯病の管理に不可欠です。PCRはまた、MRSAやC. difficileのような薬剤耐性株の早期検出を可能にすることで、院内感染対策においても重要な役割を果たしています。

感染症以外では、PCRは遺伝学的スクリーニングや出生前スクリーニングに不可欠であり、一塩基多型（SNP）、遺伝子融合、染色体異常を検出します。腫瘍診断学は、腫瘍中の実用的な変異を同定し、標的治療を導き、最小残存病変をモニターするために、PCRベースのアッセイにますます依存しています。非臨床領域では、PCRは水質検査、農業病原体検出、食品汚染スクリーニングに使用されており、その業界横断的な有用性と標準化が強調されています。

どのような技術的進歩がPCR検査プラットフォームを再形成しているか？

PCR技術の進化は、より高いスループット、より速いサイクリング時間、より高い多重化能力、および改善されたポイントオブケア（POC）適用性へのニーズによって形作られてきました。従来のサーマルサイクラーは、サンプル調製、増幅、検出を1つの密閉ユニットで行う統合システムに取って代わられ、あるいは補完されつつあります。これにより、特にリソースの限られた環境やフィールドベースの環境では、コンタミネーションのリスクが軽減され、ワークフローが簡素化されます。

デジタルPCR（dPCR）は過去10年間における最も重要な進歩の一つです。PCR反応を数千のナノリットルスケールの反応に分割することにより、dPCRは標準曲線を必要とせずに核酸の絶対定量を可能にします。このテクノロジーは、リキッドバイオプシーアプリケーションやウイルス負荷モニタリングにおいて、低存在量の標的でより高い精度を提供するため、腫瘍学で支持を集めています。ラボオンチッププラットフォームを含むマイクロ流体ベースのPCR装置もまた、緊急診断やモバイルヘルスアプリケーションに不可欠な小型化と超高速処理を可能にしています。

マルチプレックスPCR技術は、シンドロミックパネル検査の増加により、1回の反応でより多くのターゲットを処理できるように改良されています。これは、症状が重複する呼吸器疾患や消化器疾患の診断に特に有用です。複雑な増幅データを解釈し、診断の可能性を示唆し、アウトブレイク監視や患者記録統合のための集中データベースにフィードできるAI統合PCRプラットフォームが出現しつつあります。これらのスマートシステムは、診断データの収集、処理、利用方法を再定義すると期待されています。

PCR市場拡大の原動力となっているエンドユーズセグメントと世界地域は？

病院、診断リファレンスラボ、学術研究センター、バイオテクノロジー企業、公衆衛生機関がPCR検査技術の中心的なエンドユーザーです。病院ベースの分子ラボは、検査バックログを削減し、迅速な臨床意思決定をサポートするために、高スループットPCRワークフローの自動化に焦点を当てています。リファレンスラボは複数の疾患領域にわたって大量の検査を処理し、しばしばマルチプレックスおよびdPCRプラットフォームを使用して検査メニューを拡大し、受託研究をサポートしています。

研究機関は遺伝子編集実験の検証、遺伝子発現のプロファイリング、微生物シーケンスの実施にPCRを使用しています。バイオ医薬品企業は、臨床試験における製品安全性試験、コンタミネーションコントロール、ファーマコゲノミックスクリーニングのためにPCRベースのアッセイに依存しています。規制機関や食品安全当局は、世界サプライチェーン全体で遺伝子組み換え生物（GMO）、毒素、または禁止物質を追跡するためにPCRを利用し、公衆衛生基準の遵守を保証しています。

地理的には、確立されたラボのインフラ、分子検査に対する保険償還、米国を拠点とするバイオテクノロジー企業による継続的な技術革新により、北米が採用でリードしています。欧州は、協調的な公衆衛生スクリーニング・プログラムやEUを拠点とする診断薬メーカーに支えられており、僅差で2位につけています。アジア太平洋は、特に中国、インド、東南アジアで急速な成長を遂げており、感染症負担、公衆衛生への投資、分子検査能力の向上が需要を牽引しています。ラテンアメリカとアフリカは、まだ新興市場であるが、世界ヘルスへの資金提供やパンデミック対策プログラムを通じてPCRの導入が増加しています。

世界のPCR検査市場の成長を促進している要因は？

世界のPCR検査市場の成長は、早期かつ正確な診断に対する根強いニーズ、感染症負担の増加、腫瘍学や遺伝子検査におけるアプリケーションの拡大、PCRの自動化、小型化、多重化における継続的な進歩によってもたらされます。ヘルスケアが精密医療にシフトするにつれ、核酸ベースの検査に対する需要は臨床と非臨床の両方で高まっています。

ウイルスアウトブレイク、抗菌剤耐性、人獣共通感染症などの継続的な脅威は、迅速で多重化された病原体検出が可能なリアルタイムPCRプラットフォームへの投資に拍車をかけています。診断能力を強化するための政府のイニシアチブは、WHO、CDC、ゲイツ財団からの資金提供とともに、特に十分なサービスを受けていない地域において、より広範なPCR検査の利用を可能にしています。家庭用分子キットやPOCデバイスのような分散型検査におけるPCRの新たな用途は、施設ラボを超えて市場を拡大しています。

さらに、コンパニオン診断、移植モニタリング、出生前スクリーニング、個別化治療モニタリングにおけるPCRの役割の拡大は、市場の長期的な関連性を保証しています。規制状況も成熟しつつあり、検査キットの承認、緊急使用許可、品質管理基準に関するパスウェイが増加しています。分子生物学が現代医学を支え続ける中、PCR技術は引き続き不可欠で、柔軟性があり、拡張性の高いツールであり、永続的な成長の態勢を整えています。

セグメント

検査タイプ（標準、リアルタイム、デジタル、その他の検査タイプ）、製品タイプ（装置、試薬・消耗品、ソフトウェア・サービス）、適応症（感染症、腫瘍、遺伝性疾患、その他の適応症）、エンドユーザー（病院・診療所、製薬・バイオテクノロジー産業、診断センター、その他のエンドユーザー）

調査対象企業の例

• Abbott Laboratories
• Agilent Technologies
• Becton, Dickinson & Co.（BD）
• BGI Genomics
• Bio-Rad Laboratories
• Cepheid（Danaher）
• DiaSorin S.p.A.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Fujirebio
• GenMark Diagnostics
• Hologic
• Illumina Inc.
• LabCorp
• Luminex Corporation
• Meridian Bioscience
• Myriad Genetics
• Oxford Nanopore Technologies
• PerkinElmer
• Qiagen N.V.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global PCR Tests Market to Reach US$32.5 Billion by 2030

The global market for PCR Tests estimated at US$23.8 Billion in the year 2024, is expected to reach US$32.5 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Standard PCR Test, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Real-Time PCR Test segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 8.8% CAGR

The PCR Tests market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global PCR Tests Market - Key Trends & Drivers Summarized

Why Are PCR Tests Still the Gold Standard in Molecular Diagnostics?

Polymerase Chain Reaction (PCR) testing continues to stand at the forefront of molecular diagnostics due to its high specificity, sensitivity, and versatility in detecting nucleic acids across a broad spectrum of pathogens, genetic conditions, and oncology biomarkers. While initially introduced as a tool for basic research, PCR has become central to clinical diagnostics, food safety testing, forensic analysis, and environmental monitoring. Its application surged globally during the COVID-19 pandemic, and its relevance continues to evolve across routine diagnostics and precision medicine.

In infectious disease diagnostics, PCR remains the gold standard for confirming active infections, with real-time quantitative PCR (qPCR) and multiplex PCR systems offering rapid turnaround and the ability to detect multiple targets simultaneously. These capabilities are essential for managing respiratory infections (e.g., influenza, RSV, SARS-CoV-2), sexually transmitted infections, and tropical diseases such as dengue and Zika. PCR also plays a crucial role in hospital-acquired infection control by enabling early detection of drug-resistant strains like MRSA or C. difficile.

Outside infectious disease, PCR is integral in genetic and prenatal screening, detecting single-nucleotide polymorphisms (SNPs), gene fusions, and chromosomal abnormalities. Oncology diagnostics increasingly rely on PCR-based assays to identify actionable mutations in tumors, guide targeted therapies, and monitor minimal residual disease. In non-clinical domains, PCR is used in water testing, agricultural pathogen detection, and food contamination screening, emphasizing its cross-industry utility and standardization.

What Technological Advancements Are Reshaping PCR Testing Platforms?

The evolution of PCR technologies has been shaped by a need for higher throughput, faster cycling times, greater multiplexing capability, and improved point-of-care (POC) applicability. Traditional thermal cyclers are being replaced or supplemented by integrated systems combining sample preparation, amplification, and detection in a single closed unit. This reduces contamination risks and simplifies workflow, particularly in resource-limited or field-based settings.

Digital PCR (dPCR) represents one of the most significant advances in the last decade. By partitioning the PCR reaction into thousands of nanoliter-scale reactions, dPCR enables absolute quantification of nucleic acids without the need for standard curves. This technology is gaining traction in oncology for liquid biopsy applications and in viral load monitoring, offering higher precision in low-abundance targets. Microfluidic-based PCR devices, including lab-on-a-chip platforms, are also enabling miniaturization and ultra-fast processing, crucial for emergency diagnostics and mobile health applications.

Multiplex PCR technologies are being refined to handle increasing numbers of targets in a single reaction, driven by the rise in syndromic panel testing. This is especially valuable for diagnosing respiratory or gastrointestinal diseases where symptoms overlap. AI-integrated PCR platforms are emerging that can interpret complex amplification data, suggest probable diagnoses, and feed into centralized databases for outbreak surveillance or patient record integration. These smart systems are expected to redefine how diagnostic data is collected, processed, and utilized.

Which End-Use Segments and Global Regions Are Fueling PCR Market Expansion?

Hospitals, diagnostic reference laboratories, academic research centers, biotechnology firms, and public health agencies are the core end-users of PCR test technologies. Hospital-based molecular labs are focusing on automating high-throughput PCR workflows to reduce test backlogs and support rapid clinical decision-making. Reference labs process large test volumes across multiple disease domains, often using multiplex and dPCR platforms to expand test menus and support contract research.

Research institutions use PCR to validate gene editing experiments, profile gene expression, and perform microbial sequencing. Biopharma firms depend on PCR-based assays for product safety testing, contamination control, and pharmacogenomic screening in clinical trials. Regulatory bodies and food safety authorities utilize PCR to track genetically modified organisms (GMOs), toxins, or banned substances across global supply chains, ensuring compliance with public health standards.

Geographically, North America leads in adoption due to well-established lab infrastructure, insurance reimbursement for molecular tests, and ongoing innovation from U.S.-based biotech companies. Europe is a close second, supported by coordinated public health screening programs and EU-based diagnostic manufacturers. Asia-Pacific is witnessing rapid growth, especially in China, India, and Southeast Asia, where infectious disease burden, public health investment, and rising molecular lab capacity drive demand. Latin America and Africa, while still emerging markets, are experiencing increased PCR deployment through global health funding initiatives and pandemic preparedness programs.

What Factors Are Propelling Growth in the Global PCR Tests Market?

The growth in the global PCR tests market is driven by the persistent need for early and accurate diagnosis, increasing infectious disease burden, expanding applications in oncology and genetic testing, and continual advancements in PCR automation, miniaturization, and multiplexing. As healthcare shifts toward precision medicine, the demand for nucleic acid-based testing is rising across both clinical and non-clinical settings.

Ongoing threats of viral outbreaks, antimicrobial resistance, and zoonotic diseases are fueling investments in real-time PCR platforms capable of rapid, multiplexed pathogen detection. Government initiatives to strengthen diagnostic capacity, along with funding from WHO, CDC, and Gates Foundation, are enabling broader PCR test availability, particularly in underserved regions. Emerging uses of PCR in decentralized testing, such as at-home molecular kits and POC devices, are expanding the market beyond institutional labs.

Moreover, PCR’s expanding role in companion diagnostics, transplant monitoring, prenatal screening, and personalized therapy monitoring ensures long-term market relevance. The regulatory landscape is also maturing, with increased pathways for test kit approvals, emergency use authorizations, and quality control standards. With molecular biology continuing to underpin modern medicine, PCR technologies remain indispensable, flexible, and highly scalable tools poised for enduring growth.

SCOPE OF STUDY:

The report analyzes the PCR Tests market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Standard PCR Test, Real-Time PCR Test, Digital PCR Test, Other Test Types); Product Type (Instruments, Reagents & Consumables, Software & Services); Indication (Infectious Diseases, Oncology, Genetic Disorders, Other Indications); End-Use (Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Agilent Technologies
• Becton, Dickinson & Co. (BD)
• BGI Genomics
• Bio-Rad Laboratories
• Cepheid (Danaher)
• DiaSorin S.p.A.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Fujirebio
• GenMark Diagnostics
• Hologic
• Illumina Inc.
• LabCorp
• Luminex Corporation
• Meridian Bioscience
• Myriad Genetics
• Oxford Nanopore Technologies
• PerkinElmer
• Qiagen N.V.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • PCR Tests - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Post-Pandemic Focus on Molecular Diagnostics Throws the Spotlight on PCR Test Capabilities
  • Expansion of Decentralized and Point-of-Care Testing Drives Demand for Portable PCR Platforms
  • Emergence of Multiplex Testing Technologies Strengthens Business Case for PCR-Based Panels
  • Rising Infectious Disease Surveillance Initiatives Propel Routine Use of PCR Tests
  • Genetic Testing and Precision Medicine Trends Accelerate Use of PCR in Clinical Diagnostics
  • Technological Advancements in Real-Time PCR Enhance Speed, Accuracy, and Sensitivity
  • Demand for Rapid Turnaround in Hospital Settings Fuels Growth in High-Throughput PCR Instruments
  • Adoption of PCR in Food Safety and Agricultural Testing Expands Industrial Application Base
  • Regulatory Approvals for At-Home PCR Kits Create Direct-to-Consumer Market Opportunities
  • Integration with LIMS and Digital Health Platforms Enables Remote PCR Test Management
  • Increasing Focus on Antimicrobial Resistance Drives Use of PCR in Pathogen Identification
  • Research and Academic Sector Investment Supports Broad Adoption of qPCR and Digital PCR
  • Rising Prevalence of Hereditary and Rare Diseases Spurs Growth in Gene Mutation Detection Tests
  • Collaboration with Diagnostic Labs Enhances Product Accessibility and Test Customization
  • Growth in Companion Diagnostics and Oncology Drives PCR Adoption in Targeted Therapy Pathways
  • Development of Open-Access PCR Platforms Supports Flexible Assay Development in Labs
  • Demand for Saliva- and Swab-Based Non-Invasive Tests Expands Consumer PCR Testing Preference
  • Supply Chain Stability and Reagent Availability Drive Strategic Sourcing and Vendor Lock-In
  • AI and Cloud-Based Data Analytics Tools Strengthen Post-PCR Data Interpretation and Automation
  • Expansion of Veterinary Diagnostics Propels Use of PCR in Livestock and Zoonotic Surveillance
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World PCR Tests Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for PCR Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Standard PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Standard PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Standard PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Real-Time PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Real-Time PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Real-Time PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Digital PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Digital PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Digital PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Genetic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pharma & Biotech Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pharma & Biotech Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Pharma & Biotech Industries End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Diagnostics Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• JAPAN
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• CHINA
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• EUROPE
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for PCR Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• FRANCE
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• GERMANY
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for PCR Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• AUSTRALIA
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• INDIA
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for PCR Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for PCR Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
• AFRICA
  • PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030

IV. COMPETITION